Bendamustine Plus Subcutaneous Rituximab in Patients With Diffuse Large B-cell Lymphoma
Clinical trial NCT02753062 · UNKNOWN
Trial details
- NCT number
- NCT02753062
- Sponsor
- Asan Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2018-08-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.